Today Vascular dementia has no approved treatments. U of A scientists hope to change that with an inflammation-fighting drug candidate. After Alzheimer's, vascular dementia is the second-most common type of dementia. Following more than a decade of development in the lab, researchers are preparing to evaluate a novel peptide in humans.
Sept. 18, 2026 Loss of Y chromosome in men could be early warning sign of cancer New research has found that Y chromosome loss occurs in healthy-seeming tissue before tumors begin to form, making the loss of a hormone an early indicator of cancer danger.
Aug. 27, 2026 U of A's MD/PhD program grows, thanks to $2.3M NIH grant The NIH recently granted the U of A College of Medicine – Tucson nearly $2.3 million over five years to fund additional seats for students pursuing dual doctoral and medical degrees.
Aug. 4, 2026 5 things you might not know about the brown recluse Few spiders elicit as much fear as the brown recluse, but most people are far less likely to run into one or get bitten than they think, according to U of A researcher Matthew Cordes.
Feb. 20, 2026 The brain cells long called 'support' found to be critical for aversive memory A new study reveals that astrocytes, the supposed "support cells" that are spread all over the brain, are as important as neurons in fear memory.
Nov. 12, 2025 U of A scientists recognized with prestigious NIH 'New Innovator' awards U of A researchers Shang Song and M. Maya Kaelberer each received the National Institutes of Health's prestigious New Innovator Award.
Sept. 19, 2025 U of A and UNM win joint $43.6M NIH award to help turn clinical research into practical medicine The CTSA grant, the largest infrastructure and training award from the NIH, supports the translation of research discoveries into improved patient care.
Sept. 19, 2024 Samples from Huanan Seafood Market provide further evidence of COVID-19 animal origins A new study provides a shortlist of the wildlife species present at the market from which SARS-CoV-2, the virus responsible for the COVID-19 pandemic, most likely arose.
Sept. 16, 2024 Researchers take power and efficiency of biological sensing to record level Researchers have developed a new biological sensing method that can detect substances at miniscule amounts, which is immediately useful for drug testing and other research.